The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps Peptide Law: A Healthcare Attorney's Guide to the FD&C Act and Unapproved Drugs Holt Law Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest